JP2007525444A5 - - Google Patents

Download PDF

Info

Publication number
JP2007525444A5
JP2007525444A5 JP2006509414A JP2006509414A JP2007525444A5 JP 2007525444 A5 JP2007525444 A5 JP 2007525444A5 JP 2006509414 A JP2006509414 A JP 2006509414A JP 2006509414 A JP2006509414 A JP 2006509414A JP 2007525444 A5 JP2007525444 A5 JP 2007525444A5
Authority
JP
Japan
Prior art keywords
cells
tissue
cell
composition
reservoir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006509414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007525444A (ja
Filing date
Publication date
Priority claimed from US10/808,927 external-priority patent/US20040191215A1/en
Application filed filed Critical
Publication of JP2007525444A publication Critical patent/JP2007525444A/ja
Publication of JP2007525444A5 publication Critical patent/JP2007525444A5/ja
Pending legal-status Critical Current

Links

JP2006509414A 2003-03-25 2004-03-25 治療応答を誘導するための組成物 Pending JP2007525444A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45770203P 2003-03-25 2003-03-25
US10/808,927 US20040191215A1 (en) 2003-03-25 2004-03-24 Compositions for induction of a therapeutic response
PCT/US2004/009526 WO2004087065A2 (en) 2003-03-25 2004-03-25 Compositions for induction of a therapeutic response

Publications (2)

Publication Number Publication Date
JP2007525444A JP2007525444A (ja) 2007-09-06
JP2007525444A5 true JP2007525444A5 (cg-RX-API-DMAC7.html) 2009-04-02

Family

ID=32994882

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006509414A Pending JP2007525444A (ja) 2003-03-25 2004-03-25 治療応答を誘導するための組成物

Country Status (4)

Country Link
US (1) US20040191215A1 (cg-RX-API-DMAC7.html)
EP (1) EP1605899A2 (cg-RX-API-DMAC7.html)
JP (1) JP2007525444A (cg-RX-API-DMAC7.html)
WO (1) WO2004087065A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050277576A1 (en) * 2000-04-06 2005-12-15 Franco Wayne P Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
US20070111935A1 (en) * 2000-04-06 2007-05-17 Franco Wayne P Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
US9694038B2 (en) 2000-04-06 2017-07-04 Wayne P. Franco Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
US10281478B2 (en) 2000-04-06 2019-05-07 Wayne P. Franco Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
WO2006002152A1 (en) * 2004-06-21 2006-01-05 The Cleveland Clinic Foundation Ccr ligands for stem cell homing
US8048446B2 (en) * 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
US20070004973A1 (en) * 2005-06-15 2007-01-04 Tan Sharon M L Tissue treatment methods
WO2007123391A1 (en) * 2006-04-20 2007-11-01 Academisch Ziekenhuis Leiden Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly expressed gene.
US11224635B2 (en) 2007-03-27 2022-01-18 Venturis Thereuptics, Inc. Therapeutic angiogenesis for treatment of the spine and other tissues
US8983570B2 (en) * 2007-03-27 2015-03-17 Cardiovascular Biotherapeutics, Inc. Therapeutic angiogenesis for treatment of the spine
WO2009067245A2 (en) * 2007-11-20 2009-05-28 University Of Florida Research Foundation, Inc. Compositions and methods for tissue repair
RU2491076C2 (ru) * 2008-03-31 2013-08-27 Аугустинус БАДЕР Способ и композиция для регенерации тканей с помощью стволовых или костномозговых клеток
JP2010214019A (ja) * 2009-03-18 2010-09-30 Chiba Univ ノッチシグナルを利用した虚血組織再生方法
BRPI1012036A2 (pt) 2009-05-27 2017-10-10 Selecta Biosciences Inc nanocarreadores que possuem componentes com diferentes taxas de liberação
WO2011014563A1 (en) 2009-07-29 2011-02-03 Vatrix Medical, Inc. Tissue stabilization for heart failure
WO2011044443A2 (en) * 2009-10-09 2011-04-14 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Matricryptic ecm peptides for tissue reconstruction
WO2011119738A2 (en) 2010-03-23 2011-09-29 The Johns Hopkins University Methods of treatment using stem cell mobilizers
CA2798739A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Nanocarrier compositions with uncoupled adjuvant
US20120093764A1 (en) * 2010-10-19 2012-04-19 Dipnarine Maharaj Treatment of diabetes using g-csf and hyperbaric oxygen
US9267934B2 (en) * 2010-10-26 2016-02-23 University Of South Alabama Methods and compositions for ameliorating pancreatic cancer
KR20140050698A (ko) 2011-07-29 2014-04-29 셀렉타 바이오사이언시즈, 인크. 체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
WO2013167156A1 (en) * 2012-05-11 2013-11-14 Otto-Von-Guericke-Universität Magdeburg Transplantation of modified monocytes
CA3162890A1 (en) * 2019-11-25 2021-06-03 The Penn State Research Foundation Composition and method for converting human glial cells into neurons

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
MX9203290A (es) * 1983-09-19 1992-08-01 Liposome Co Inc Suministro localizado usando conjugados de fibronectina.
US5328471A (en) * 1990-02-26 1994-07-12 Endoluminal Therapeutics, Inc. Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US6152141A (en) * 1994-07-28 2000-11-28 Heartport, Inc. Method for delivery of therapeutic agents to the heart
US6239172B1 (en) * 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
FI972433A0 (fi) * 1994-12-08 1997-06-06 Glaxo Group Ltd Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
WO1997023256A1 (en) * 1995-12-22 1997-07-03 Localmed, Inc. Localized intravascular delivery of growth factors for promotion of angiogenesis
US6045565A (en) * 1997-11-04 2000-04-04 Scimed Life Systems, Inc. Percutaneous myocardial revascularization growth factor mediums and method
US6663899B2 (en) * 1997-06-13 2003-12-16 Genentech, Inc. Controlled release microencapsulated NGF formulation
US5980548A (en) * 1997-10-29 1999-11-09 Kensey Nash Corporation Transmyocardial revascularization system
US20030113303A1 (en) * 1998-02-05 2003-06-19 Yitzhack Schwartz Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
US7067109B1 (en) * 1998-07-13 2006-06-27 Board Of Regents, The University Of Texas System Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
IL125532A0 (en) * 1998-07-27 1999-03-12 Yeda Res & Dev Hematopoietic cell composition for use in transplantation
US6363938B2 (en) * 1998-12-22 2002-04-02 Angiotrax, Inc. Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth
AU4544600A (en) * 1999-04-06 2000-10-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
US20020110538A1 (en) * 1999-12-28 2002-08-15 Health Research, Inc. Methods and products for tumor immunotherapy using cytokines
US6627442B1 (en) * 2000-08-31 2003-09-30 Virxsys Corporation Methods for stable transduction of cells with hiv-derived viral vectors
JP2004520043A (ja) * 2001-01-24 2004-07-08 シェーリング　コーポレイション 免疫応答のアジュバントとしてのケモカイン
US6660034B1 (en) * 2001-04-30 2003-12-09 Advanced Cardiovascular Systems, Inc. Stent for increasing blood flow to ischemic tissues and a method of using the same

Similar Documents

Publication Publication Date Title
JP2007525444A5 (cg-RX-API-DMAC7.html)
JP2007525444A (ja) 治療応答を誘導するための組成物
KR101639827B1 (ko) 10 내지 20 미크론의 직경을 갖는 미세구를 포함하는 비경구형 조성물
JP5383757B2 (ja) 薬剤放出生分解性繊維インプラント
JP6850734B2 (ja) 眼の障害の処置のためのカプセル化細胞療法の使用
AU3368895A (en) Device for delivery of substances and methods of use thereof
EP3691738B1 (en) Implantable bioreactor
US20130309304A1 (en) Compounds and methods
US20260061009A1 (en) Methods of treating diabetes using devices for cellular transplantation
CN101282652B (zh) 预血管化的装置及相关方法
CN105764538A (zh) 用于无免疫抑制剂的移植的装置、方法和使用
Choi et al. Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction
US20170095592A1 (en) Compositions For An Injectable, In Situ Forming Neuroscaffold And Methods Of Using The Same
CN110035742A (zh) 干细胞仿生微粒
CN101123977A (zh) 用于诱导治疗应答的组合物
CN112203667A (zh) 大包封的治疗性细胞、装置及其使用方法
KR102572188B1 (ko) 매크로-캡슐화 치료 세포 및 이의 사용 방법
Carnes Tuning the Biophysical and Biochemical Cues of Fibrin Microthread Scaffolds Towards the Treatment of Volumetric Muscle Loss
CN121648162A (zh) 一种心功能制剂及其制备方法和应用
CN119633170A (zh) 一种调控局部炎症微环境促神经再生的复合微球的制备方法
Zapata et al. Growth Factor Delivery Systems for the Treatment of Cardiovascular Diseases